Browsing: Bristol

Investing.com — Jefferies upgraded Bristol-Myers Squibb Company (NYSE:) from Hold to Buy and raised its price target by $7 to…

NEW YORK (Reuters) – Bristol Myers Squibb was hit with a $6.7 billion lawsuit on Thursday, alleging it defrauded former…

By Christy Santhosh and Unnamalai L (Reuters) -The U.S. Food and Drug Administration has approved Bristol Myers (NYSE:) Squibb’s combination…